NCT06409845Completed
Effectiveness and Tolerability of Eptinezumab
Effectiveness and Tolerability of Eptinezumab: a Prospective, Multicentric, Cohort Study
Source: ClinicalTrials.gov · Last updated 11 Jun 2026
Brief summary (registry, in English)
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of eptinezumab as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 130 (actual)
- First submitted
- 5 Apr 2024
- Start date
- 26 Mar 2024
- Primary completion date
- 1 Apr 2025
- Lead sponsor
- University of Florence
- Diseases
- Migraine
- NCT number
- NCT06409845
What you commit to
- Study type: Observational
- Participants enrolled: 130
- From 26 Mar 2024 to the primary completion date, 1 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant diagnosis of medical diseases and/or comorbidities that, in the Investigator's opinion might interfere with study assessments;
- Changes in preventive treatments in the month before the first administration of eptinezumab
Other
- Subjects with contraindications for use of eptinezumab;
- medical comorbidities that could interfere with study results;
- Pregnancy and breastfeeding
Who the study is looking for
- Diagnosis of migraine without aura, migraine with aura, or chronic migraine according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III);
- Good compliance to study procedures;
- Availability of headache diary at least of the preceding months before enrolment;
- At least 8 monthly migraine days.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SISC Coordinator of this site? Confirm its status | Florence | Italy | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.